Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. We show 13 historical shares outstanding datapoints in our MRVI shares outstanding history coverage, used to compute MRVI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing MRVI market cap history over the course of time is important for investors
interested in comparing MRVI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of MRVI versus a peer is one thing; comparing
MRVI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like MRVI can fluctuate over the course of history.
With this page we aim to empower investors researching MRVI by allowing them to research the MRVI market cap history. |
Free MRVI Email Alerts:
Video: The Importance of Market Cap
